Journal profile · Immunology
Immunological Investigations
ISSN 0882-0139 · eISSN 1532-4311 · Informa Healthcare · UNITED STATES · Quarterly
Immunological Investigations: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.95; subscription journal; APC charged, amount not published; review about 31 days (first decision after review, publisher); community-reported acceptance: fairly easy; 76 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Immunological Investigations is published by Informa Healthcare and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Immune Cell Function and Interaction, T-cell and B-cell Immunology and Monoclonal and Polyclonal Antibodies Research, together about 38.1% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Disseminating immunological developments on a worldwide basis, Immunological Investigations provides a truly in-depth examination of the latest advances in molecular and cellular immunology by reporting on all facets of fundamental and applied immunology that include (but are not limited to): the development, activation and control of innate and adaptive immune cells, immunity to infectious diseases and cancer, transplantation, allergy, autoimmunity, immunodeficiencies, vaccines and immunotherapies, the interaction between the microbiome or metabolic diseases and immune function, mucosal immunity, aging and immunity, immune regulation of cardiovascular and neurological diseases, immunogenetics, immunohematology, and immunological techniques. Investigators are encouraged to submit original research articles that report novel findings, as well as review articles that cover new and emerging topics. Immunological Investigations accepts Research Articles, Review Articles, Data Notes, Methods and Article Commentaries for publication. Immunological Investigations operates a single-anonymized peer review policy.
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editor-in-chief John D. ColganPublisher website
Editorial board by country: none in mainland China; most named United States 4 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Cell Function and InteractionImmunology and Microbiology14.1%
- T-cell and B-cell ImmunologyImmunology and Microbiology13.8%
- Monoclonal and Polyclonal Antibodies ResearchMedicine10.2%
- Immunotherapy and Immune ResponsesImmunology and Microbiology9.1%
- Immune Response and InflammationImmunology and Microbiology7.7%
- Glycosylation and Glycoproteins ResearchBiochemistry, Genetics and Molecular Biology3.7%
- Immune cells in cancerImmunology and Microbiology3.6%
- Systemic Lupus Erythematosus ResearchMedicine3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCurrent ContentsPublisher website
Other: CABI, VINITI RAN - Referativnyi Zhurnal
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.95LetPub ·
- Impact factor (publisher) 2025
- 2.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.3Publisher website ·
- CiteScore 2026-06
- 5.7LetPub ·
- CiteScore (publisher) 2025
- 5.7Publisher website ·
- SJR 2026-06
- 0.65LetPub ·
- SJR (publisher) 2025
- 0.65Publisher website ·
- SNIP 2026-06
- 0.65LetPub ·
- SNIP (publisher) 2025
- 0.65Publisher website ·
- h-index
- 42LetPub ·
- h-index
- 71OpenAlex ·
- i10-index
- 1,170OpenAlex ·
- 2-year mean citedness
- 2.28OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 3.2%LetPub ·
Volume
- Articles per year
- 75LetPub ·
- Downloads per year (publisher)
- 85,000Publisher website ·
- Downloads per year (publisher) 2025
- 85,000Publisher website ·
Articles by year OpenAlex count · 2,547 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 82 | 2 | 10 |
| 2025 | 76 | 6 | 163 |
| 2024 | 85 | 21 | 380 |
| 2023 | 60 | 23 | 396 |
| 2022 | 57 | 21 | 636 |
| 2021 | 84 | 14 | 1,066 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
31 daysfirst decision after review · community reports 6–12 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 10%Publisher website ·
- Acceptance rate (publisher) 2025
- 10%Publisher website ·
- Submission to first decision
- 6 daysPublisher website ·
- Submission to first decision 2025
- 6 daysPublisher website ·
- First decision after review
- 31 daysPublisher website ·
- First decision after review 2025
- 31 daysPublisher website ·
- Acceptance to publication
- 13 daysPublisher website ·
- Acceptance to publication 2025
- 13 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted5
- article commentariesImmunological Investigations accepts Research Articles, Review Articles, Data Notes, Methods and Article Commentaries for publication.Length not stated
- data notesImmunological Investigations accepts Research Articles, Review Articles, Data Notes, Methods and Article Commentaries for publication.Length not stated
- methodsImmunological Investigations accepts Research Articles, Review Articles, Data Notes, Methods and Article Commentaries for publication.Length not stated
- research articlesImmunological Investigations accepts Research Articles, Review Articles, Data Notes, Methods and Article Commentaries for publication.Length not stated
- review articlesImmunological Investigations accepts Research Articles, Review Articles, Data Notes, Methods and Article Commentaries for publication.Length not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Immunological Investigations is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverabilit…
Source ↗Publisher website ·- Peer review
Single-anonymized peer review Model summary
Immunological Investigations operates a single-anonymized peer review policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- ISSN
- 0882-0139
- Electronic ISSN
- 1532-4311
- Latest issue on the website
- Volume 55, Issue 6 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Immunological Investigations
What CAS zone is Immunological Investigations in?
In the 2025 upgraded edition of the CAS Journal Ranking, Immunological Investigations is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Immunological Investigations?
The latest impact factor listed by LetPub is 2.95; CiteScore 5.7, h-index 71.
How long does peer review take at Immunological Investigations?
The publisher reports about 31 days (first decision after review); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 10% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Immunological Investigations based?
Of the 4 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Immunological Investigations?
According to LetPub and DOAJ records, Immunological Investigations is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is Immunological Investigations open access, and what is the APC?
Immunological Investigations is a subscription journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .